U.S. Markets closed

Market Trends Toward New Normal in Shutterstock, CrossAmerica Partners LP, Allegiance Bancshares, Portola Pharmaceuticals, StoneMor Partners, and Catalyst Biosciences — Emerging Consolidated Expectations, Analyst Ratings

NEW YORK, Sept. 05, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Shutterstock, Inc. (SSTK), CrossAmerica Partners LP (CAPL), Allegiance Bancshares, Inc. (ABTX), Portola Pharmaceuticals, Inc. (PTLA), StoneMor Partners L.P. (STON), and Catalyst Biosciences, Inc. (CBIO), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

SSTK DOWNLOAD: http://Fundamental-Markets.com/register/?so=SSTK
CAPL DOWNLOAD: http://Fundamental-Markets.com/register/?so=CAPL
ABTX DOWNLOAD: http://Fundamental-Markets.com/register/?so=ABTX
PTLA DOWNLOAD: http://Fundamental-Markets.com/register/?so=PTLA
STON DOWNLOAD: http://Fundamental-Markets.com/register/?so=STON
CBIO DOWNLOAD: http://Fundamental-Markets.com/register/?so=CBIO

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Shutterstock, Inc. (SSTK), CrossAmerica Partners LP (CAPL), Allegiance Bancshares, Inc. (ABTX), Portola Pharmaceuticals, Inc. (PTLA), StoneMor Partners L.P. (STON), and Catalyst Biosciences, Inc. (CBIO) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed August 31st, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

SHUTTERSTOCK, INC. (SSTK) REPORT OVERVIEW

Shutterstock's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Shutterstock reported revenue of $156.58MM vs $134.00MM (up 16.86%) and basic earnings per share -$0.01 vs $0.09. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Shutterstock reported revenue of $557.11MM vs $494.32MM (up 12.70%) and basic earnings per share $0.48 vs $0.93 (down 48.39%). Shutterstock is expected to report earnings on October 30th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.18. The estimated EPS forecast for the next fiscal year is $1.15 and is expected to report on February 28th, 2019.

To read the full Shutterstock, Inc. (SSTK) report, download it here: http://Fundamental-Markets.com/register/?so=SSTK

-----------------------------------------

CROSSAMERICA PARTNERS LP (CAPL) REPORT OVERVIEW

CrossAmerica Partners LP's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, CrossAmerica Partners LP reported revenue of $673.30MM vs $528.79MM (up 27.33%) and basic earnings per share -$0.21 vs -$0.15. For the twelve months ended December 31st, 2017 vs December 31st, 2016, CrossAmerica Partners LP reported revenue of $2,094.83MM vs $1,869.81MM (up 12.03%) and basic earnings per share $0.56 vs $0.22 (up 154.55%). CrossAmerica Partners LP is expected to report earnings on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.09. The estimated EPS forecast for the next fiscal year is -$0.06 and is expected to report on February 25th, 2019.

To read the full CrossAmerica Partners LP (CAPL) report, download it here: http://Fundamental-Markets.com/register/?so=CAPL

-----------------------------------------

ALLEGIANCE BANCSHARES, INC. (ABTX) REPORT OVERVIEW

Allegiance Bancshares' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Allegiance Bancshares reported interest income of $34.19MM vs $28.99MM (up 17.96%) and basic earnings per share $0.57 vs $0.41 (up 39.02%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Allegiance Bancshares reported interest income of $119.44MM vs $100.78MM (up 18.52%) and basic earnings per share $1.34 vs $1.78 (down 24.72%). Allegiance Bancshares is expected to report earnings on October 23rd, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.22. The estimated EPS forecast for the next fiscal year is $3.14 and is expected to report on January 24th, 2019.

To read the full Allegiance Bancshares, Inc. (ABTX) report, download it here: http://Fundamental-Markets.com/register/?so=ABTX

-----------------------------------------

PORTOLA PHARMACEUTICALS, INC. (PTLA) REPORT OVERVIEW

Portola Pharmaceuticals' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Portola Pharmaceuticals reported revenue of $4.01MM vs $3.79MM (up 5.91%) and basic earnings per share -$1.61 vs -$1.22. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Portola Pharmaceuticals reported revenue of $22.55MM vs $35.50MM (down 36.50%) and basic earnings per share -$4.81 vs -$4.76. Portola Pharmaceuticals is expected to report earnings on November 5th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$1.41. The estimated EPS forecast for the next fiscal year is -$3.97 and is expected to report on February 27th, 2019.

To read the full Portola Pharmaceuticals, Inc. (PTLA) report, download it here: http://Fundamental-Markets.com/register/?so=PTLA

-----------------------------------------

STONEMOR PARTNERS L.P. (STON) REPORT OVERVIEW

StoneMor Partners' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, StoneMor Partners reported revenue of $85.30MM vs $88.31MM (down 3.41%) and basic earnings per share -$1.19 vs -$0.16. For the twelve months ended December 31st, 2017 vs December 31st, 2016, StoneMor Partners reported revenue of $338.23MM vs $326.23MM (up 3.68%) and basic earnings per share -$1.96 vs -$0.94. StoneMor Partners is expected to report earnings on December 11th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.30. The estimated EPS forecast for the next fiscal year is -$0.60 and is expected to report on March 6th, 2019.

To read the full StoneMor Partners L.P. (STON) report, download it here: http://Fundamental-Markets.com/register/?so=STON

-----------------------------------------

CATALYST BIOSCIENCES, INC. (CBIO) REPORT OVERVIEW

Catalyst Biosciences' Recent Financial Performance

For the twelve months ended December 31st, 2017 vs December 31st, 2016, Catalyst Biosciences reported revenue of $1.02MM vs $0.40MM (up 155.14%) and basic earnings per share -$7.45 vs -$21.75. Catalyst Biosciences is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$1.34. The estimated EPS forecast for the next fiscal year is -$3.42 and is expected to report on March 7th, 2019.

To read the full Catalyst Biosciences, Inc. (CBIO) report, download it here: http://Fundamental-Markets.com/register/?so=CBIO

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.